LeonaBio (LONA) Retained Earnings (2019 - 2026)
LeonaBio (LONA) posted quarterly Retained Earnings of -$13000.0 for Q1 2026, down 225.0% year-over-year from $10400.0 in Q1 2025, and down 225.0% quarter-over-quarter from -$4000.0 in Q4 2025.
LeonaBio (LONA) Retained Earnings (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has reported Retained Earnings for 8 consecutive years, with -$13000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 225.0% year-over-year to -$13000.0; the TTM figure through Mar 2026 stood at -$13000.0 (down 225.0% YoY), while the FY2025 annual figure was -$4000.0, down 500.0% from the prior year.
- Retained Earnings retreated to -$13000.0 in Q1 2026 per LONA's latest filing, from -$4000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $3000.0 in Q3 2024 and bottomed at -$335.5 million in Q1 2024.
- Historically, Retained Earnings has averaged -$64.4 million across 5 years, with a median of -$349000.0 in 2023.
- Annual changes were most pronounced in 2023 — Retained Earnings sank 14965.52% — and 2024, when it jumped 100.29%.
- LeonaBio's Retained Earnings stood at -$2.0 million in 2022, then soared by 82.16% to -$349000.0 in 2023, then surged by 100.29% to $1000.0 in 2024, then tumbled by 500.0% to -$4000.0 in 2025, then sank by 225.0% to -$13000.0 in 2026.
- Business Quant data shows LONA's Retained Earnings at -$13000.0 in Q1 2026, -$4000.0 in Q4 2025, and -$2000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | LeonaBio | 180.91 Mn | 129.85 Mn | - | -563.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | -38,000.00 |
| Mar 31, 2024 | -335.54 Mn |
| Dec 31, 2023 | -349,000.00 |
| Sep 30, 2023 | -281.92 Mn |
| Jun 30, 2023 | -248.95 Mn |
| Mar 31, 2023 | -219.35 Mn |
| Dec 31, 2022 | -1.96 Mn |
| Sep 30, 2022 | -2.47 Mn |
| Jun 30, 2022 | -1.93 Mn |
| Mar 31, 2022 | -1.46 Mn |
| Dec 31, 2021 | -388,000.00 |
| Sep 30, 2021 | -79.56 Mn |
| Jun 30, 2021 | 37,000.00 |